Kymera Therapeutics, Inc. - COMMON STOCK (KYMR)

CUSIP: 501575104

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 7 signals
Share change
+1,981,264
Put/Call ratio
3.1%
SEC-reported price per share
$63.49
Number of holders
123
Value change
+$128,644,677
Number of buys
73
Open additional details 1 more signal available
Number of sells
40
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
82,930,729

Security key

501575104

Report period

Q4 2021

Institutions

123

Top holders

10

Ownership snapshot

Top reported holders of KYMR - Kymera Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ATLAS VENTURE ASSOCIATES ...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
0/15
Latest evidence
30 Sep 2021
3/4/5 13F Highest disclosed value: $189,918,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PRICE T ROWE ASSOCIATES INC /MD/ has the largest disclosed position value at $189.92M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Disclosed position value Top 5
ATLAS VENTURE ASSOCIATES X, L.P. $173.16M
PRICE T ROWE ASSOCIATES INC /MD/ $189.92M
BVF INC/IL $186.83M
BlackRock Finance, Inc. $178.6M
VANGUARD GROUP INC $170.44M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ATLAS VENTURE ASSOCIATES X, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$173,161,222
5,763,012 shares
— 11 Aug 2021
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$189,918,000
3,233,197 shares
— 30 Sep 2021
BVF INC/IL
13F
Company
13F
—
denominator unverified
$186,832,000
3,180,658 shares
— 30 Sep 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$178,595,000
3,040,431 shares
— 30 Sep 2021
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$170,438,000
2,901,574 shares
— 30 Sep 2021
Redmile Group, LLC
13F
Company
13F
—
denominator unverified
$164,102,000
2,793,708 shares
— 30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
123
Shares
43,015,870
Rows available
123
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
115
Q4 2021 holders
123
Holder diff
8
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .